Heightened Proinflammatory Glycosylation of Borrelia burgdorferi IgG Antibodies in Synovial Fluid in Patients With Antibiotic‐Refractory Lyme Arthritis

Arthritis RheumatolPublished Mechanistic study

Authors' conclusion

Patients with oral antibiotic-responsive LA had Bb IgG1 antibodies with more balanced proinflammatory/antiinflammatory glycan profiles, whereas patients with antibiotic-refractory LA had Bb IgG1 antibodies with maximal, minimally opposed, proinflammatory glycan profiles.

Study context

Population
Patients with Lyme arthritis; serum and synovial fluid samples
Participants
21 patients
Comparison
Antibiotic-responsive vs antibiotic-refractory Lyme arthritis
Outcome
Glycan profiles of total IgG1 and Bb-specific IgG1 antibodies and their correlation with treatment outcome
Methodological detailsGlycoblotting with hydrazide glycan enrichment and MALDI-TOF mass spectrometry after affinity-column processing
  • Glycoblotting with hydrazide glycan enrichment and MALDI-TOF mass spectrometry after affinity-column processing

Main finding

As reported in the abstract

  • Antibiotic-responsive Lyme arthritis (LA) vs refractory LA: total and Borrelia burgdorferi (Bb)-specific IgG1 glycans with less intense inflammatory profiles (lower % GlcNAc and bisecting GlcNAc, higher % galactose and fucose)
  • Refractory LA before IV antibiotics: maximal, minimally opposed, proinflammatory glycan profiles (high % GlcNAc and bisecting GlcNAc, intermediate % galactose and fucose, low % sialic acid)
  • Refractory LA seen after IV antibiotics: Bb IgG1 with strongly inflammatory glycan profiles, but inflammatory potential appeared to be waning

Original publication

Heightened Proinflammatory Glycosylation of Borrelia burgdorferi IgG Antibodies in Synovial Fluid in Patients With Antibiotic‐Refractory Lyme Arthritis. Arthritis Rheumatol. Published 11 May 2023. doi:10.1002/art.42465

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.